Human TAFII31 protein is a transcriptional coactivator of the p53 protein.
Author(s) -
Hua Lu,
Arnold J. Levine
Publication year - 1995
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.92.11.5154
Subject(s) - taf2 , transcription factor ii d , general transcription factor , transcription factor ii a , coactivator , taf1 , taf4 , rna polymerase ii , tata box binding protein , biology , tata binding protein , microbiology and biotechnology , gatad2b , transcription factor ii b , transcription (linguistics) , transcription factor , dna binding protein , biochemistry , rna polymerase , rna , gene , promoter , gene expression , repressor , enhancer , linguistics , philosophy
The p53 protein activates transcription of a target gene by binding to a specific DNA response element and interacting with the transcriptional apparatus of RNA polymerase II. The amino-terminal domain of p53 interacts with a component of the TFIID basal transcription complex. The human TATA-binding-protein-associated factor TAFII31, a component of TFIID, has been identified as a critical protein required for p53-mediated transcriptional activation. TAFII31 and p53 proteins bind to each other via amino acid residues in the amino-terminal domain of p53 that are essential for transcription. Antibodies directed against TAFII31 protein inhibit p53-activated but not basal transcription in vitro. These results demonstrate that TAFII31 is a coactivator for the p53 protein.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom